Abstract
BackgroundSignificant improvements in disease activity and long term physical function have been documented following approval of biologic therapies for treatment of RA since 1998 [1, 2].ObjectivesTo determine if fewer RA...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
